Review



marker cd47  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bioss marker cd47
    <t>CD47</t> expression in striatal neurons of R6/2 mice. Confocal laser scanning microscopy images of double-label immunofluorescence for CD47 (visualized in red fluorescence) and the Nissl-like fluorescent marker Neurotrace (visualized in green fluorescence). (A–D) Images show the expression pattern of CD47 in the striatum of 5 and 13 weeks-old wild-type mice and in 5 and 13 weeks-old R6/2 mice. (E,F) Detail of cytoplasmic membrane CD47 expression in 13 weeks-old Wt mice. In 13 weeks-old R6/2 mice CD47 is lower due to cell death process (G) Histogram shows CD47 intensity quantification which is significantly decreased in the striatal neurons of 13 weeks-old R6/2 mice [Genotype effect F (1,153) = 11.97, *** P = 0.0007]. (H,I) Tukey’s multiple comparisons analysis revealed a significant protein decrease of striatal neuronal CD47, as evaluated by western blotting in R6/2 mice [Genotype effect F (1,20) = 8.667, ** P = 0.0080; Time effect F (1,20) = 5.802, ** P = 0.0258; Genotype X Time Interaction F (1,20) = 37.89, *** P < 0,0001].
    Marker Cd47, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/marker cd47/product/Bioss
    Average 94 stars, based on 4 article reviews
    marker cd47 - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Neuroimmune pathways involvement in neurodegeneration of R6/2 mouse model of Huntington’s disease"

    Article Title: Neuroimmune pathways involvement in neurodegeneration of R6/2 mouse model of Huntington’s disease

    Journal: Frontiers in Cellular Neuroscience

    doi: 10.3389/fncel.2024.1360066

    CD47 expression in striatal neurons of R6/2 mice. Confocal laser scanning microscopy images of double-label immunofluorescence for CD47 (visualized in red fluorescence) and the Nissl-like fluorescent marker Neurotrace (visualized in green fluorescence). (A–D) Images show the expression pattern of CD47 in the striatum of 5 and 13 weeks-old wild-type mice and in 5 and 13 weeks-old R6/2 mice. (E,F) Detail of cytoplasmic membrane CD47 expression in 13 weeks-old Wt mice. In 13 weeks-old R6/2 mice CD47 is lower due to cell death process (G) Histogram shows CD47 intensity quantification which is significantly decreased in the striatal neurons of 13 weeks-old R6/2 mice [Genotype effect F (1,153) = 11.97, *** P = 0.0007]. (H,I) Tukey’s multiple comparisons analysis revealed a significant protein decrease of striatal neuronal CD47, as evaluated by western blotting in R6/2 mice [Genotype effect F (1,20) = 8.667, ** P = 0.0080; Time effect F (1,20) = 5.802, ** P = 0.0258; Genotype X Time Interaction F (1,20) = 37.89, *** P < 0,0001].
    Figure Legend Snippet: CD47 expression in striatal neurons of R6/2 mice. Confocal laser scanning microscopy images of double-label immunofluorescence for CD47 (visualized in red fluorescence) and the Nissl-like fluorescent marker Neurotrace (visualized in green fluorescence). (A–D) Images show the expression pattern of CD47 in the striatum of 5 and 13 weeks-old wild-type mice and in 5 and 13 weeks-old R6/2 mice. (E,F) Detail of cytoplasmic membrane CD47 expression in 13 weeks-old Wt mice. In 13 weeks-old R6/2 mice CD47 is lower due to cell death process (G) Histogram shows CD47 intensity quantification which is significantly decreased in the striatal neurons of 13 weeks-old R6/2 mice [Genotype effect F (1,153) = 11.97, *** P = 0.0007]. (H,I) Tukey’s multiple comparisons analysis revealed a significant protein decrease of striatal neuronal CD47, as evaluated by western blotting in R6/2 mice [Genotype effect F (1,20) = 8.667, ** P = 0.0080; Time effect F (1,20) = 5.802, ** P = 0.0258; Genotype X Time Interaction F (1,20) = 37.89, *** P < 0,0001].

    Techniques Used: Expressing, Confocal Laser Scanning Microscopy, Immunofluorescence, Fluorescence, Marker, Membrane, Western Blot



    Similar Products

    94
    Bioss marker cd47
    <t>CD47</t> expression in striatal neurons of R6/2 mice. Confocal laser scanning microscopy images of double-label immunofluorescence for CD47 (visualized in red fluorescence) and the Nissl-like fluorescent marker Neurotrace (visualized in green fluorescence). (A–D) Images show the expression pattern of CD47 in the striatum of 5 and 13 weeks-old wild-type mice and in 5 and 13 weeks-old R6/2 mice. (E,F) Detail of cytoplasmic membrane CD47 expression in 13 weeks-old Wt mice. In 13 weeks-old R6/2 mice CD47 is lower due to cell death process (G) Histogram shows CD47 intensity quantification which is significantly decreased in the striatal neurons of 13 weeks-old R6/2 mice [Genotype effect F (1,153) = 11.97, *** P = 0.0007]. (H,I) Tukey’s multiple comparisons analysis revealed a significant protein decrease of striatal neuronal CD47, as evaluated by western blotting in R6/2 mice [Genotype effect F (1,20) = 8.667, ** P = 0.0080; Time effect F (1,20) = 5.802, ** P = 0.0258; Genotype X Time Interaction F (1,20) = 37.89, *** P < 0,0001].
    Marker Cd47, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/marker cd47/product/Bioss
    Average 94 stars, based on 1 article reviews
    marker cd47 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd47 immunohistochemistry marker mouse monoclonal b6h12
    A. Strong membranous staining is observed in HRS cells using <t>CD47</t> <t>immunohistochemistry</t> at 200× magnification. The staining highlights the robust expression of CD47 on the cell membrane, indicative of its significant presence on these malignant cells, B: A dot-like staining pattern is visible in the Golgi zone of a subset of HRS cells at 400× magnification, C: Nuclear positivity is widespread in HRS cells, as detected by Epstein–Barr virus-encoded RNA (EBER) in situ hybridization (ISH) at 200× magnification.
    Cd47 Immunohistochemistry Marker Mouse Monoclonal B6h12, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd47 immunohistochemistry marker mouse monoclonal b6h12/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    cd47 immunohistochemistry marker mouse monoclonal b6h12 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Galectin Therapeutics cd47 protein marker
    Hybrid exosome-based drug delivery systems representing the source, synthetic carrier, hybridization technique, and outcomes <xref ref-type= a " width="250" height="auto" />
    Cd47 Protein Marker, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd47 protein marker/product/Galectin Therapeutics
    Average 90 stars, based on 1 article reviews
    cd47 protein marker - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    BioMimetic Therapeutics biomimetic self-marker cd47-functionalization
    Hybrid exosome-based drug delivery systems representing the source, synthetic carrier, hybridization technique, and outcomes <xref ref-type= a " width="250" height="auto" />
    Biomimetic Self Marker Cd47 Functionalization, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biomimetic self-marker cd47-functionalization/product/BioMimetic Therapeutics
    Average 90 stars, based on 1 article reviews
    biomimetic self-marker cd47-functionalization - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Leuko Labs cd47 protein marker
    Hybrid exosome-based drug delivery systems representing the source, synthetic carrier, hybridization technique, and outcomes <xref ref-type= a " width="250" height="auto" />
    Cd47 Protein Marker, supplied by Leuko Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd47 protein marker/product/Leuko Labs
    Average 90 stars, based on 1 article reviews
    cd47 protein marker - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    BioMimetic Therapeutics camouflaging self-marker cd47-functionalization
    Hybrid exosome-based drug delivery systems representing the source, synthetic carrier, hybridization technique, and outcomes <xref ref-type= a " width="250" height="auto" />
    Camouflaging Self Marker Cd47 Functionalization, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/camouflaging self-marker cd47-functionalization/product/BioMimetic Therapeutics
    Average 90 stars, based on 1 article reviews
    camouflaging self-marker cd47-functionalization - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Bio-Rad monoclonal mouse anti rat antibody markers
    Hybrid exosome-based drug delivery systems representing the source, synthetic carrier, hybridization technique, and outcomes <xref ref-type= a " width="250" height="auto" />
    Monoclonal Mouse Anti Rat Antibody Markers, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal mouse anti rat antibody markers/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    monoclonal mouse anti rat antibody markers - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    CD47 expression in striatal neurons of R6/2 mice. Confocal laser scanning microscopy images of double-label immunofluorescence for CD47 (visualized in red fluorescence) and the Nissl-like fluorescent marker Neurotrace (visualized in green fluorescence). (A–D) Images show the expression pattern of CD47 in the striatum of 5 and 13 weeks-old wild-type mice and in 5 and 13 weeks-old R6/2 mice. (E,F) Detail of cytoplasmic membrane CD47 expression in 13 weeks-old Wt mice. In 13 weeks-old R6/2 mice CD47 is lower due to cell death process (G) Histogram shows CD47 intensity quantification which is significantly decreased in the striatal neurons of 13 weeks-old R6/2 mice [Genotype effect F (1,153) = 11.97, *** P = 0.0007]. (H,I) Tukey’s multiple comparisons analysis revealed a significant protein decrease of striatal neuronal CD47, as evaluated by western blotting in R6/2 mice [Genotype effect F (1,20) = 8.667, ** P = 0.0080; Time effect F (1,20) = 5.802, ** P = 0.0258; Genotype X Time Interaction F (1,20) = 37.89, *** P < 0,0001].

    Journal: Frontiers in Cellular Neuroscience

    Article Title: Neuroimmune pathways involvement in neurodegeneration of R6/2 mouse model of Huntington’s disease

    doi: 10.3389/fncel.2024.1360066

    Figure Lengend Snippet: CD47 expression in striatal neurons of R6/2 mice. Confocal laser scanning microscopy images of double-label immunofluorescence for CD47 (visualized in red fluorescence) and the Nissl-like fluorescent marker Neurotrace (visualized in green fluorescence). (A–D) Images show the expression pattern of CD47 in the striatum of 5 and 13 weeks-old wild-type mice and in 5 and 13 weeks-old R6/2 mice. (E,F) Detail of cytoplasmic membrane CD47 expression in 13 weeks-old Wt mice. In 13 weeks-old R6/2 mice CD47 is lower due to cell death process (G) Histogram shows CD47 intensity quantification which is significantly decreased in the striatal neurons of 13 weeks-old R6/2 mice [Genotype effect F (1,153) = 11.97, *** P = 0.0007]. (H,I) Tukey’s multiple comparisons analysis revealed a significant protein decrease of striatal neuronal CD47, as evaluated by western blotting in R6/2 mice [Genotype effect F (1,20) = 8.667, ** P = 0.0080; Time effect F (1,20) = 5.802, ** P = 0.0258; Genotype X Time Interaction F (1,20) = 37.89, *** P < 0,0001].

    Article Snippet: Coronal brain sections were incubated with the marker CD47 (BS-21460R, rabbit polyclonal anti-CD47, Bioss, USA) at 1:200 dilution in a 0.1 M PB solution containing 0.3% Triton X-100 for 72 h at 4°C.

    Techniques: Expressing, Confocal Laser Scanning Microscopy, Immunofluorescence, Fluorescence, Marker, Membrane, Western Blot

    A. Strong membranous staining is observed in HRS cells using CD47 immunohistochemistry at 200× magnification. The staining highlights the robust expression of CD47 on the cell membrane, indicative of its significant presence on these malignant cells, B: A dot-like staining pattern is visible in the Golgi zone of a subset of HRS cells at 400× magnification, C: Nuclear positivity is widespread in HRS cells, as detected by Epstein–Barr virus-encoded RNA (EBER) in situ hybridization (ISH) at 200× magnification.

    Journal: Turkish Journal of Medical Sciences

    Article Title: Does CD47 expression have prognostic significance in classical Hodgkin lymphoma?

    doi: 10.55730/1300-0144.5958

    Figure Lengend Snippet: A. Strong membranous staining is observed in HRS cells using CD47 immunohistochemistry at 200× magnification. The staining highlights the robust expression of CD47 on the cell membrane, indicative of its significant presence on these malignant cells, B: A dot-like staining pattern is visible in the Golgi zone of a subset of HRS cells at 400× magnification, C: Nuclear positivity is widespread in HRS cells, as detected by Epstein–Barr virus-encoded RNA (EBER) in situ hybridization (ISH) at 200× magnification.

    Article Snippet: All cases were stained using the CD47 immunohistochemistry marker (mouse monoclonal B6H12, catalog no: 14-0479-82, Invitrogen Thermo Fisher Scientific, 1:100 dilution).

    Techniques: Staining, Immunohistochemistry, Expressing, Membrane, Virus, In Situ Hybridization

    Comparison of CD47 staining score with IPI. The scatterplot shows the distribution of International Prognostic Index (IPI) scores as a function of CD47 expression (%). Each red cross represents an individual data point. The blue contour shading represents kernel density estimation (KDE), highlighting the concentration of data points within the sample population. This visualization demonstrates the overall distribution and density of the data points, suggesting a potential trend or relationship between CD47 expression and IPI score.

    Journal: Turkish Journal of Medical Sciences

    Article Title: Does CD47 expression have prognostic significance in classical Hodgkin lymphoma?

    doi: 10.55730/1300-0144.5958

    Figure Lengend Snippet: Comparison of CD47 staining score with IPI. The scatterplot shows the distribution of International Prognostic Index (IPI) scores as a function of CD47 expression (%). Each red cross represents an individual data point. The blue contour shading represents kernel density estimation (KDE), highlighting the concentration of data points within the sample population. This visualization demonstrates the overall distribution and density of the data points, suggesting a potential trend or relationship between CD47 expression and IPI score.

    Article Snippet: All cases were stained using the CD47 immunohistochemistry marker (mouse monoclonal B6H12, catalog no: 14-0479-82, Invitrogen Thermo Fisher Scientific, 1:100 dilution).

    Techniques: Comparison, Staining, Expressing, Concentration Assay

    The distribution of age, sex, IPI, EBER, and marker results according to  CD47  coding for the 120 patients evaluated in the study.

    Journal: Turkish Journal of Medical Sciences

    Article Title: Does CD47 expression have prognostic significance in classical Hodgkin lymphoma?

    doi: 10.55730/1300-0144.5958

    Figure Lengend Snippet: The distribution of age, sex, IPI, EBER, and marker results according to CD47 coding for the 120 patients evaluated in the study.

    Article Snippet: All cases were stained using the CD47 immunohistochemistry marker (mouse monoclonal B6H12, catalog no: 14-0479-82, Invitrogen Thermo Fisher Scientific, 1:100 dilution).

    Techniques: Marker, Comparison

    Hybrid exosome-based drug delivery systems representing the source, synthetic carrier, hybridization technique, and outcomes <xref ref-type= a " width="100%" height="100%">

    Journal: Nanoscale Advances

    Article Title: A comprehensive review of challenges and advances in exosome-based drug delivery systems

    doi: 10.1039/d4na00501e

    Figure Lengend Snippet: Hybrid exosome-based drug delivery systems representing the source, synthetic carrier, hybridization technique, and outcomes a

    Article Snippet: These hybrid exosomes were shown to have individual cell specific protein markers of RBC (CD47) and MCF-7 (EpCAM, galectin 3, and cadherin) and were loaded with DOX.

    Techniques: Hybridization, Marker, Liposomes, Encapsulation, Incubation, Transfection, Isolation, Expressing, Plasmid Preparation, CRISPR, In Vivo, Control, Suspension, Membrane, Derivative Assay, Clinical Proteomics, Imaging, Binding Assay, Labeling, Fluorescence, MTT Assay